Danial M Ignas1, Andrea S Doria2, Annette von Drygalski3, Victor S Blanchette1,4, Eric Y Chang5, Saunya Dover1, Kathelijn Fischer6, Sridhar Gibikote7, Shyamkumar N Keshava7, Felipe Querol8, Audrey Abad1, Paul Babyn9. 1. Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. 2. Department of Medical Imaging, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. 3. Hemophilia and Thrombosis Treatment Center, Department of Medicine, Division of Hematology/Oncology, University of California, San Diego, CA, USA. 4. Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. 5. Radiology Service, VA San Diego Healthcare System, University of California, San Diego, San Diego, CA, USA. 6. Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands. 7. Department of Radiology, Christian Medical College, Vellore, India. 8. Haemostasis and Thrombosis Unit, Hospital LA FE, Universidad de Valencia, Valencia, Spain. 9. Department of Medical Imaging, University of Saskatchewan and Saskatchewan Health Authority Saskatoon City Hospital, Saskatoon, SK, Canada.
Abstract
AIM: The objective of this survey was to understand the global trends of imaging assessments in persons with haemophilia, focusing on point-of-care ultrasound (POCUS). Insights into the barriers impeding its widespread proliferation as a frontline imaging modality were obtained. METHODS: The survey opened in September of 2017 and closed in May of 2018. Haemophilia Treatment Centres (HTCs) treating both paediatric/adult patients were the population of interest. A REDCap survey of 25 questions was disseminated to 232 clinical staff in 26 countries. RESULTS: The majority of respondents (88.3%, 91/103) reported that POCUS is most useful to confirm or rule out a presumed acute joint bleed. European HTCs reported the highest routine use of POCUS at 59.5% (22/37) followed by HTCs in the "Other" countries of the world at 46.7% (7/15) and North American HTCs at 43.9% (25/57). At the time of the survey, physiotherapists were identified as the clinical staff who perform POCUS 52.8% (28/53) of the time, in contrast with nurses/nurse practitioners who represent only 5.7% (3/53) of users. The greatest perceived barriers to the implementation of POCUS are the lack of trained healthcare professionals who can perform POCUS at 69.2% (74/107) and the overall time commitment required at 68.2% (73/107). CONCLUSION: Despite POCUS being used in 49.5% (54/109) of sampled HTCs, it is still utilized almost 30% less globally than full diagnostic ultrasound. A list of barriers has been identified to inform HTCs which challenges they will likely need to overcome should they choose to incorporate this imaging modality into their practice.
AIM: The objective of this survey was to understand the global trends of imaging assessments in persons with haemophilia, focusing on point-of-care ultrasound (POCUS). Insights into the barriers impeding its widespread proliferation as a frontline imaging modality were obtained. METHODS: The survey opened in September of 2017 and closed in May of 2018. Haemophilia Treatment Centres (HTCs) treating both paediatric/adult patients were the population of interest. A REDCap survey of 25 questions was disseminated to 232 clinical staff in 26 countries. RESULTS: The majority of respondents (88.3%, 91/103) reported that POCUS is most useful to confirm or rule out a presumed acute joint bleed. European HTCs reported the highest routine use of POCUS at 59.5% (22/37) followed by HTCs in the "Other" countries of the world at 46.7% (7/15) and North American HTCs at 43.9% (25/57). At the time of the survey, physiotherapists were identified as the clinical staff who perform POCUS 52.8% (28/53) of the time, in contrast with nurses/nurse practitioners who represent only 5.7% (3/53) of users. The greatest perceived barriers to the implementation of POCUS are the lack of trained healthcare professionals who can perform POCUS at 69.2% (74/107) and the overall time commitment required at 68.2% (73/107). CONCLUSION: Despite POCUS being used in 49.5% (54/109) of sampled HTCs, it is still utilized almost 30% less globally than full diagnostic ultrasound. A list of barriers has been identified to inform HTCs which challenges they will likely need to overcome should they choose to incorporate this imaging modality into their practice.
Authors: Akram Mesleh Shayeb; Richard F W Barnes; Cris Hanacek; Peter Aguero; Bruno Steiner; Cindy Bailey; Doris Quon; Rebecca Kruse-Jarres; Annette von Drygalski Journal: Haemophilia Date: 2021-06-25 Impact factor: 4.263
Authors: Nihal Bakeer; Saunya Dover; Paul Babyn; Brian M Feldman; Annette von Drygalski; Andrea S Doria; Danial M Ignas; Audrey Abad; Cindy Bailey; Ian Beggs; Eric Y Chang; Amy Dunn; Sharon Funk; Sridhar Gibikote; Nicholas Goddard; Pamela Hilliard; Shyamkumar N Keshava; Rebecca Kruse-Jarres; Yingjia Li; Sébastien Lobet; Marilyn Manco-Johnson; Carlo Martinoli; James S O'Donnell; Olympia Papakonstantinou; Helen Pergantou; Pradeep Poonnoose; Felipe Querol; Alok Srivastava; Bruno Steiner; Karen Strike; Merel Timmer; Pascal N Tyrrell; Logi Vidarsson; Victor S Blanchette Journal: Res Pract Thromb Haemost Date: 2021-07-10